Throughout my career in immunology and biotechnology, I have become increasingly convinced that one of the most important factors in developing better therapies is our ability to measure what is happening inside the body. We can have a strong scientific hypothesis and an innovative treatment approach, but without reliable ways to understand disease and measure a patient’s response, development becomes much more difficult. This is where biomarkers play such an important role.
A biomarker is a measurable indicator of a biological process, disease state, or response to treatment. In simple terms, biomarkers give us information about what is happening in a patient. They can help researchers understand disease mechanisms, identify appropriate patients for a clinical trial, determine whether a therapy is having its intended effect, and monitor how a patient responds over time.
As our understanding of biology becomes more sophisticated, biomarkers are becoming increasingly important to the development of new therapies.
Identifying the Right Patients
One of the biggest challenges in drug development is that patients who share the same diagnosis may not have the same underlying biology. A disease such as an autoimmune disorder or neurodegenerative condition can involve multiple biological pathways, and those pathways may differ considerably between individuals.
This creates a problem when testing a new therapy. If a treatment is designed to target a particular mechanism, but a clinical trial includes many patients who do not have that mechanism driving their disease, the results may not accurately reflect the potential value of the treatment.
Biomarkers can help address this issue by identifying patients who are most likely to benefit. Instead of treating a large population as though everyone has the same disease biology, researchers can begin to divide patients into groups based on measurable characteristics.
This approach can make clinical development more focused and potentially increase the chances of identifying a meaningful therapeutic effect.
Understanding Whether a Therapy Is Working
Another important role for biomarkers is helping us determine whether a treatment is having the intended biological effect. In a traditional development program, researchers may have to wait for clinical outcomes before determining whether a therapy is working.
Those outcomes remain essential, but they can take considerable time to measure. A well-designed biomarker can provide information much earlier in the development process.
For example, if a therapy is designed to alter a particular immune pathway, researchers may be able to measure changes in immune activity before changes in symptoms become apparent. This does not replace clinical outcomes, but it provides another layer of information that can help researchers understand what is happening.
The ability to see biological changes earlier can help guide development decisions and determine whether a therapeutic approach deserves further investment.
Supporting Better Clinical Trials
Biomarkers can also improve the design of clinical trials. Selecting appropriate patients is one part of this, but biomarkers can also help researchers establish more precise measures of disease activity and treatment response.
This is particularly valuable when studying complex diseases where symptoms may vary significantly between patients. A biomarker can provide an objective measurement that complements clinical assessments.
Better trial design can reduce uncertainty and help researchers learn more from every study. In an industry where clinical development requires substantial time and investment, the ability to generate high-quality information efficiently is extremely valuable.
The Importance of Biomarkers in Immunology
My background in immunology has given me a particular appreciation for the role biomarkers can play in understanding the immune system. The immune response involves many different cells, molecules, and signaling pathways, all interacting dynamically.
A patient may appear clinically similar to another patient while having a very different immune profile. Understanding those differences can help us determine why some patients respond to a particular therapy while others do not.
As technologies such as single-cell analysis and advanced molecular profiling continue to develop, our ability to characterize immune states is becoming more sophisticated. These tools provide researchers with an increasingly detailed picture of what individual cells are doing and how they interact.
This information has the potential to support more precise therapeutic development and better patient selection.
Biomarkers and Cell Therapy
Biomarkers are also becoming increasingly important as cell therapies become more sophisticated. Engineered cells can be designed to perform specific functions, but researchers need ways to determine whether those cells are behaving as intended after they are introduced into the body.
This may involve monitoring the presence, persistence, activity, or effects of therapeutic cells. Understanding these characteristics can provide valuable information about both safety and efficacy.
For emerging cell therapies, this information can be particularly important because developers are often working with technologies that have relatively limited clinical history. Biomarkers can help bridge the gap between what researchers observe in the laboratory and what is happening inside patients.
Helping Guide Difficult Decisions
Biotechnology development involves many decisions about where to invest time and resources. Not every scientific hypothesis will succeed, and not every promising therapy will demonstrate sufficient benefit in clinical studies.
Biomarkers can provide important evidence when making these decisions. If a therapy is not producing the expected biological response, researchers may need to reconsider the mechanism or development strategy. If the expected biological effect is present but clinical outcomes are not improving, that can also provide valuable information.
The goal is not to use biomarkers to force a particular conclusion. The goal is to use reliable biological information to make better decisions.
The Challenge of Finding the Right Biomarker
Developing a useful biomarker is not always straightforward. A measurement may be scientifically interesting without being sufficiently reliable or clinically meaningful.
The best biomarkers need to be carefully validated. Researchers must understand what they measure, how consistently they can be measured, and how closely they relate to the disease or therapeutic response.
This requires collaboration among scientists, clinicians, statisticians, and regulatory experts. A biomarker must ultimately be useful within the context of the therapy and the patient population being studied.
Looking Toward the Future
I believe biomarkers will become increasingly central to the future of therapeutic development. As medicine becomes more personalized, our ability to measure individual biology will become just as important as our ability to design new treatments.
Advances in genomics, proteomics, single-cell technologies, imaging, and computational analysis are creating opportunities to measure disease with greater precision. These technologies could help us identify patients earlier, predict treatment response, monitor disease progression, and develop therapies that are better matched to individual biology.
The challenge will be turning enormous amounts of biological information into measurements that are practical, reliable, and useful in clinical development.
Closing Thoughts
The development of a new therapy is a long and complicated process. Biomarkers cannot eliminate every challenge, but they can provide researchers with better information at critical stages of development.
For me, the most valuable aspect of biomarkers is their ability to connect biological understanding with practical decision making. They help us see what is happening beneath the surface and provide evidence that can guide the development of new treatments.
As we continue moving toward more precise therapies, biomarkers will play an increasingly important role in understanding patients, improving clinical trials, and accelerating promising treatments toward the people who need them. The better we become at measuring biology, the better positioned we are to turn scientific discoveries into meaningful advances in medicine.